Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2012
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalencePhilip R Spradling, Loralee Rupp, Anne C Moorman, et al.Digestive Diseases and Sciences|October 2, 2017
A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis CJian Xing, Philip R Spradling, Anne C Moorman, et al.Infectious Disease Clinics of North America|May 21, 2018
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of FindingsAnne C Moorman, Loralee B Rupp, Stuart C Gordon, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS)Danae Bixler, Yuna Zhong, Kathleen N Ly, et al.Journal of Viral Hepatitis|February 26, 2018
Impact of sustained virologic response on risk of type 2 diabetes among hepatitis C patients in the United StatesJ Li, T Zhang, S C Gordon, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 22, 2017
Changing trends in complications of chronic hepatitis CMei Lu, Jia Li, Loralee B Rupp, et al.Alimentary Pharmacology & Therapeutics|January 17, 2019
Sustained virological response to hepatitis C treatment decreases the incidence of complications associated with type 2 diabetesJia Li, Stuart C Gordon, Loralee B Rupp, et al.Hepatology (Baltimore, Md.)|August 19, 2014
Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for interventionAnne C Moorman, Jian Xing, Stephen Ko, et al.Journal of Viral Hepatitis|June 15, 2019
Adjuvant ribavirin and longer direct-acting antiviral treatment duration improve sustained virological response among hepatitis C patients at risk of treatment failureMei Lu, Kuan-Han Wu, Jia Li, et al.Journal of Clinical Gastroenterology|July 25, 2017
Race, Age, and Geography Impact Hepatitis C Genotype Distribution in the United StatesStuart C Gordon, Sheri Trudeau, Jia Li, et al.Pageof 11